Hilltelligence markHilltelligence
Archived This bill is from the 118th Congress (2023–2024) and is no longer under active consideration.
Bills/H.R. 4242118th Congress

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.

House: Referred
Cosponsors
2
Introduced
2023-06-21
Last action
2023-06-23

Referred to the Subcommittee on Health.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the Subcommittee on Health.

  2. House

    Referred to the House Committee on Energy and Commerce.

  3. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Health

Sign in to view Hilltelligence’s potential-cosponsor analysis.